Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Study sponsor: Xencor, Inc. · XNCR
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-12Estimated
Enrollment · participants270Estimated
Source updated2026-10-30Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.